These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 33967966)
1. Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask. Albertelli M; Grillo F; Lo Calzo F; Puliani G; Rainone C; Colao AAL; Faggiano A; Front Endocrinol (Lausanne); 2021; 12():680305. PubMed ID: 33967966 [TBL] [Abstract][Full Text] [Related]
2. [Neuroendocrine tumors of digestive system: morphologic spectrum and cell proliferation (Ki67 index)]. Delektorskaia VV; Kushliskiĭ NE Vestn Ross Akad Med Nauk; 2013; (5):28-37. PubMed ID: 24000665 [TBL] [Abstract][Full Text] [Related]
3. Practice patterns for reporting digestive system neuroendocrine neoplasms: results from a large, comprehensive international survey. Karamchandani DM; Cox B; La Rosa S; Bellizzi AM; Shi C; Gonzalez RS Histopathology; 2023 Mar; 82(4):541-554. PubMed ID: 36507623 [TBL] [Abstract][Full Text] [Related]
4. [Pathology of neuroendocrine neoplasms]. Anlauf M; Gerlach P; Schott M; Raffel A; Krausch M; Knoefel WT; Pavel M; Klöppel G Chirurg; 2011 Jul; 82(7):567-73. PubMed ID: 21487814 [TBL] [Abstract][Full Text] [Related]
5. Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report. Rindi G; Bordi C; La Rosa S; Solcia E; Delle Fave G; ; Dig Liver Dis; 2011 Mar; 43 Suppl 4():S356-60. PubMed ID: 21459341 [TBL] [Abstract][Full Text] [Related]
6. Expression of CD133 in neuroendocrine neoplasms of the digestive tract: a detailed immunohistochemical analysis. Mia-Jan K; Munkhdelger J; Lee MR; Ji SY; Kang TY; Choi E; Cho MY Tohoku J Exp Med; 2013 Apr; 229(4):301-9. PubMed ID: 23615455 [TBL] [Abstract][Full Text] [Related]
7. Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system - a review. Păun I; Becheanu G; Costin AI; Constantin VD; Mihai GM; Radu L; Iovan L; Vârcuş F Rom J Morphol Embryol; 2018; 59(3):673-678. PubMed ID: 30534804 [TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine neoplasm of digestive system with different grades: a clinicopathologic and prognostic study]. Zhang MH; Liu YH; Luo XL; Lin XT; Zhuang HG Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):448-51. PubMed ID: 22932454 [TBL] [Abstract][Full Text] [Related]
9. Claudin 18.2 expression in digestive neuroendocrine neoplasms: a clinicopathological study. Jiang K; Cao F; Yin L; Hu Y; Zhao X; Huang X; Ma X; Li J; Lu M; Sun Y J Endocrinol Invest; 2024 May; 47(5):1251-1260. PubMed ID: 38060154 [TBL] [Abstract][Full Text] [Related]
10. Lung and digestive neuroendocrine neoplasms. From WHO classification to biomarker screening: Which perspectives? Scoazec JY Ann Endocrinol (Paris); 2019 Jun; 80(3):163-165. PubMed ID: 31064659 [TBL] [Abstract][Full Text] [Related]
11. Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease. Miller HC; Drymousis P; Flora R; Goldin R; Spalding D; Frilling A World J Surg; 2014 Jun; 38(6):1353-61. PubMed ID: 24493070 [TBL] [Abstract][Full Text] [Related]
12. Looking into digestive mixed neuroendocrine - nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors. Uccella S; La Rosa S Histopathology; 2020 Nov; 77(5):700-717. PubMed ID: 32538468 [TBL] [Abstract][Full Text] [Related]
13. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Klöppel G; Rindi G; Anlauf M; Perren A; Komminoth P Virchows Arch; 2007 Aug; 451 Suppl 1():S9-27. PubMed ID: 17684761 [TBL] [Abstract][Full Text] [Related]
14. High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event. Knösel T; Chen Y; Altendorf-Hofmann A; Danielczok C; Freesmeyer M; Settmacher U; Wurst C; Schulz S; Yang LL; Petersen I J Cancer Res Clin Oncol; 2012 Mar; 138(3):397-403. PubMed ID: 22160160 [TBL] [Abstract][Full Text] [Related]
15. Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms. Capdevila J; Bodei L; Davies P; Gorbounova V; Jensen RT; Knigge UP; Krejs GJ; Krenning E; O'Connor JM; Peeters M; Rindi G; Salazar R; Vullierme MP; Pavel ME; ; Neuroendocrinology; 2019; 108(1):18-25. PubMed ID: 30153686 [TBL] [Abstract][Full Text] [Related]
16. Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading. Cavalcanti E; Armentano R; Valentini AM; Chieppa M; Caruso ML Cell Death Dis; 2017 Aug; 8(8):e3004. PubMed ID: 28837143 [TBL] [Abstract][Full Text] [Related]
17. Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms. La Rosa S Endocr Pathol; 2021 Jun; 32(2):245-257. PubMed ID: 33786701 [TBL] [Abstract][Full Text] [Related]
18. Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms. Klöppel G; La Rosa S Virchows Arch; 2018 Mar; 472(3):341-349. PubMed ID: 29134440 [TBL] [Abstract][Full Text] [Related]
19. Validation of a Cytotechnologist Manual Counting Service for the Ki67 Index in Neuroendocrine Tumors of the Pancreas and Gastrointestinal Tract. Cottenden J; Filter ER; Cottreau J; Moore D; Bullock M; Huang WY; Arnason T Arch Pathol Lab Med; 2018 Mar; 142(3):402-407. PubMed ID: 29293020 [TBL] [Abstract][Full Text] [Related]
20. Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites. Uccella S; La Rosa S; Metovic J; Marchiori D; Scoazec JY; Volante M; Mete O; Papotti M Endocr Pathol; 2021 Mar; 32(1):192-210. PubMed ID: 33433884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]